Quantitative measurements show lower estrogen receptor (ER) mRNA expression, higher HER2 mRNA expression, and higher prevalence of triple-negative breast cancer among tumors arising in young women [5]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.